Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Oct;21(10):e25198.
doi: 10.1002/jia2.25198.

Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator

Affiliations

Internalized HIV stigma, ART initiation and HIV-1 RNA suppression in South Africa: exploring avoidant coping as a longitudinal mediator

Valerie A Earnshaw et al. J Int AIDS Soc. 2018 Oct.

Abstract

Introduction: Cross-sectional evidence suggests that internalized HIV stigma is associated with lower likelihoods of antiretroviral therapy (ART) initiation and HIV-1 RNA suppression among people living with HIV (PLWH). This study examined these associations with longitudinal data spanning the first nine months following HIV diagnosis and explored whether avoidant coping mediates these associations.

Methods: Longitudinal data were collected from 398 South African PLWH recruited from testing centres in 2014 to 2015. Self-report data, including internalized stigma and avoidant coping (denying and distracting oneself from stressors), were collected one week and three months following HIV diagnosis. ART initiation at six months and HIV-1 RNA at nine months were extracted from the South Africa National Health Laboratory Service database. Two path analyses were estimated, one testing associations between internalized stigma, avoidant coping and ART initiation, and the other testing associations between internalized stigma, avoidant coping and HIV-1 RNA suppression.

Results: Participants were 36 years old, on average, and 63% identified as female, 18% as Zulu and 65% as Xhosa. The two path models fit the data well (ART initiation outcome: X2 (7) = 8.14, p = 0.32; root mean square error of approximation (RMSEA) = 0.02; comparative fit index (CFI) = 0.92; HIV-1 RNA suppression outcome: X2 (7) = 6.58, p = 0.47; RMSEA = 0.00; CFI = 1.00). In both models, internalized stigma one week after diagnosis was associated with avoidant coping at three months, controlling for avoidant coping at one week. In turn, avoidant coping at three months was associated with lower likelihood of ART initiation at six months in the first model and lower likelihood of HIV-1 RNA suppression at nine months in the second model. Significant indirect effects were observed between internalized stigma with ART non-initiation and unsuppressed HIV-1 RNA via the mediator of avoidant coping.

Conclusions: Internalized stigma experienced soon after HIV diagnosis predicted lower likelihood of ART initiation and HIV-1 RNA suppression over the first year following HIV diagnosis. Avoidant coping played a role in these associations, suggesting that PLWH who internalize stigma engage in greater avoidant coping, which in turn worsens medication- and health-related outcomes. Interventions are needed to address internalized stigma and avoidant coping soon after HIV diagnosis to enhance treatment efforts during the first year after HIV diagnosis.

Keywords: HIV; South Africa; antiretroviral therapy; coping; stigma.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Longitudinal structural equation model of associations between internalized stigma, avoidant coping and antiretroviral therapy initiation. Values are unstandardized regression coefficients. Model controls for socio‐demographics and substance use on avoidant coping at three months and ART initiation at six months. **p < 0.01
Figure 2
Figure 2
Longitudinal structural equation model of associations between internalized stigma, avoidant coping and HIV‐1 RNA suppression. Values are unstandardized regression coefficients. Model controls for socio‐demographics and substance use on avoidant coping at three months and HIV‐1 RNA suppression and nine months. **p < 0.01

References

    1. The Joint United Nations Programme on HIV/AIDS (UNAIDS) . Fast‐track: Ending the AIDS epidemic by 2030. Geneva, Switzerland; 2014. [cited: 2018 Oct 17] Available from: http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014repo...
    1. World Health Organization . Guideline on when to start antiretroviral therapy and on pre‐exposure prophylaxis for HIV. Geneva, Switzerland: WHO Press; 2015. ISBN: 978‐92‐4‐150956‐5. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. - PMC - PubMed
    1. The INSIGHT START Study Group . Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;2015(373):795–807. - PMC - PubMed
    1. The TEMPRANO ANRS 12136 Study Group . A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;2015(373):808–22. - PubMed

Publication types

Substances